Dr. Soliman Abdel Kader Fakeeh Hospital Future Growth
Future criteria checks 3/6
Dr. Soliman Abdel Kader Fakeeh Hospital is forecast to grow earnings and revenue by 19.7% and 16.5% per annum respectively. EPS is expected to grow by 18.3% per annum. Return on equity is forecast to be 12.9% in 3 years.
Key information
19.7%
Earnings growth rate
18.3%
EPS growth rate
Healthcare earnings growth | 14.8% |
Revenue growth rate | 16.5% |
Future return on equity | 12.9% |
Analyst coverage | Low |
Last updated | 02 Sep 2024 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 4,027 | 462 | -88 | 557 | 5 |
12/31/2025 | 3,408 | 372 | -501 | 427 | 5 |
12/31/2024 | 2,830 | 285 | -718 | 321 | 5 |
6/30/2024 | 2,586 | 274 | -29 | 251 | N/A |
3/31/2024 | 2,478 | 280 | 123 | 373 | N/A |
12/31/2023 | 2,327 | 280 | -72 | 304 | N/A |
9/30/2023 | 2,205 | 311 | -28 | 289 | N/A |
12/31/2022 | 2,012 | 326 | -138 | -15 | N/A |
12/31/2021 | 1,965 | 334 | 172 | 255 | N/A |
12/31/2020 | 1,715 | 203 | -63 | 4 | N/A |
12/31/2019 | 1,640 | 301 | -323 | -196 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 4017's forecast earnings growth (19.7% per year) is above the savings rate (14.5%).
Earnings vs Market: 4017's earnings (19.7% per year) are forecast to grow faster than the SA market (7.2% per year).
High Growth Earnings: 4017's earnings are forecast to grow, but not significantly.
Revenue vs Market: 4017's revenue (16.5% per year) is forecast to grow faster than the SA market (1.2% per year).
High Growth Revenue: 4017's revenue (16.5% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 4017's Return on Equity is forecast to be low in 3 years time (12.9%).